Xuanwu Hospital, Capital Medical University — Beijing, Beijing Municipality

Public research footprint of Xuanwu Hospital, Capital Medical University, compiled from the ClinicalTrials.gov public registry.

453

Registered studies

230

Active

138

Recruiting now

115

Completed

Stopped or withdrawn

Most-studied conditions

NF2-related Schwannomatosis · Vestibular Schwannoma · Acute Spinal Cord Injury (SCI) · Diabetes Mellitus, Type 2

Recently updated registry entries

NCT07741045 — Phase Ⅲ Clinical Trial to Evaluate the Efficacy and Safety of TJ0113 Capsules in Patients… (Not Yet Recruiting)
NCT05352919 — An Extension Study to Learn More About the Long-Term Safety of Litifilimab (BIIB059)… (Enrolling By Invitation)
NCT05327114 — Efficacy and Safety Study of Nipocalimab for Adults With Chronic Inflammatory… (Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at Xuanwu Hospital, Capital Medical University?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 03, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.